Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Prader-Willi Syndrome Treatment: Setmelanotide Phase 2 Results
Rhythm Pharmaceuticals reports a significant 7-point hyperphagia reduction in its Phase 2 trial of setmelanotide for Prader-Willi syndrome.
FDA Grants Fast Track Designation for Novel Sepsis Treatment Isupartob
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium, accelerating the clinical trials and development of a novel sepsis treatment.
Symeres Expands Spray Drying Capabilities for Complex Drug Formulation
Symeres enhances its CMC site in New Jersey with expanded spray drying capabilities, optimizing drug formulation development for poorly soluble candidates.
Alteogen Unveils Breakthrough Preclinical Results for Subcutaneous ADCs
Alteogen reveals preclinical data for an antibody-drug conjugate (ADC) subcutaneous formulation using ALT-B4, showing improved absorption and safety profiles.
JW Pharma Restores Cognitive Function with Rare Disease Drug Candidate
JW Pharmaceutical shares preclinical results for DDC-02 at the World Orphan Drug Congress, showing restored cognitive function in rare neurodevelopmental disorders.
Purple Biotech Unveils IM1240 Cancer Treatment Preclinical Data at EACR
Purple Biotech presents promising preclinical data at EACR 2026 for IM1240, a novel cancer treatment showing anti-tumor activity in hard-to-treat solid tumors.
Gilead & MSD's Once-Weekly HIV Treatment Meets Phase 3 Endpoints
Gilead and MSD's novel once-weekly oral HIV pill combining islatravir and lenacapavir achieves Phase 3 clinical trial endpoints, preparing for regulatory filing.
FDA Expands Pfizer's Hympavzi Approval to More Hemophilia Patients
The FDA approves an expanded label for Pfizer's Hympavzi, a breakthrough subcutaneous non-factor treatment for hemophilia A and B patients with inhibitors.
Clinical Cancer Trials Help Boost Long-Term Cancer Survivorship Statistics
Dr. Jennifer Diamond discusses how advanced clinical cancer trials introduce critical cellular therapies to improve post-treatment quality of life.
Advanced Breast Cancer Clinical Trials: Gedatolisib Nearly Doubles PFS
Dr. Hurvitz presents Phase 3 VIKTORIA-1 trial data showing gedatolisib nearly doubles progression-free survival in PIK3CA+ advanced breast cancer.
AI Drug Discovery and Development Boosts Phase 3 Success, Says AZ CEO
AstraZeneca CEO Pascal Soriot highlights how artificial intelligence tools optimize molecule design and predict clinical success in late-stage trials.
How Nonprofits Rescue Shelved Rare Disease Drug Pipelines From Pharma
Children’s Tumor Foundation CEO Annette Bakker discusses how the nonprofit rescues shelved rare disease drugs to accelerate clinical trial validation.
3
4
5
6
7
8
9
10
11
